Clinical Trials Logo

Osteogenesis Imperfecta clinical trials

View clinical trials related to Osteogenesis Imperfecta.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03706482 Active, not recruiting - Clinical trials for Osteogenesis Imperfecta

Boost Brittle Bones Before Birth

BOOSTB4
Start date: August 12, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

An exploratory, open label, multiple dose, multicentre phase I/II trial evaluating safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe Osteogenesis Imperfecta compared with a combination of historical and untreated prospective controls.

NCT ID: NCT02934451 Active, not recruiting - Clinical trials for Osteogenesis Imperfecta

Dental Malocclusion and Craniofacial Development in OI

Start date: August 2016
Phase:
Study type: Observational

Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss and pain and difficulty getting around. People with moderate to severe OI may also be diagnosed with dentinogenesis imperfecta (DI). DI is characterized by grey or brown teeth that may chip and wear down and break easily. People with DI may also have skull and neck defects. These patients may have severe teeth misalignment resulting in clinically significant chewing problems. Teeth misalignment in OI is very hard to treat because of the quality and quantity of bone. The overall goal of this study is to improve dental health to improve the quality of life of people with OI.

NCT ID: NCT02814591 Active, not recruiting - Osteoarthritis Clinical Trials

Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman Spectroscopy

Start date: October 2011
Phase:
Study type: Observational [Patient Registry]

In this study spatially offset Raman spectroscopy (SORS), which allows the collection of Raman spectra through turbid media, is being applied to collect Raman spectra of bone. The principal aim to find ways to use Raman spectroscopy to assess bone quality in vivo.

NCT ID: NCT02531087 Active, not recruiting - Clinical trials for Osteogenesis Imperfecta

Urinary Biomarkers of OI Pathobiology

Start date: September 2015
Phase:
Study type: Observational

Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss, dental problems, pain and difficulty getting around. Before the genetic cause of OI was known, OI was classified into four types. Each type was based upon the symptoms and severity of OI. In most people with OI, the cause is a change in one of the genes that makes a protein called type 1 collagen. Some doctors now classify OI both on how severe it is as well as which gene is causing OI. When people classify OI this way, there are more than 10 types of OI. The current laboratory testing to determine OI subtype involves the collection of blood and/or skin cells.